The demand for aortic endograft in USA is projected to grow from USD 1.3 billion in 2025 to USD 2.1 billion by 2035, at a CAGR of 4.7%. Abdominal Aortic Graft will dominate with a 62.0% market share, while endovascular aneurysm repair (evar) will lead the procedure segment with a 64.5% share.